Cancer News
OncoLink Cancer News - HealthDay

Prion Protein Eyed for Role in Pancreatic Cancer

-- Eric Metcalf

Thursday, August 20, 2009

THURSDAY, Aug. 20 (HealthDay News) -- A form of prion protein (PrP) may play a role in the aggressiveness of human pancreatic ductal adenocarcinoma (PDAC), according to research published Aug. 17 in the Journal of Clinical Investigation.

Chaoyang Li, Ph.D., of the Case Western Reserve University in Cleveland, and colleagues found that seven human PDAC cell lines expressed PrP. However, the PrP existed as a pro-protein that wasn't glycosylated or glycosylphosphatidylinositol (GPI)-anchored. The level of PrP varied among the lines, and was found both on the cell surface and in the cytoplasm.

The researchers found that binding of pro-prion protein (pro-PrP) to the filamin A (FLNa) cytolinker protein resulted in disruption of the cytoskeleton and signaling events in the PDAC lines. Inhibiting PrP expression in the cells reduced cellular proliferation and invasiveness. In addition, in patients treated surgically for pancreatic cancer, PrP expression in tumors was associated with shorter survival.

"Instead of being a GPI-anchored glycoprotein, PrP in human PDAC exists as pro-PrP, which binds to FLNa. This fatal attraction disrupts the normal functions of FLNa and confers a growth advantage to PDAC," the authors write. "Currently, there is no marker for early diagnosis of human PDAC; detection of pro-PrP could offer such a marker. Furthermore, prevention of the interaction between pro-PrP and FLNa could provide a novel target for therapeutic intervention in PDAC."

Full Text

Specialties Cardiology
Diabetes & Endocrinology
Internal Medicine
Family Practice

Copyright © 2009 ScoutNews, LLC. All rights reserved.

I Wish You Knew

Getting through cancer treatment: tips from an oncology nurse

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More